Table 2.
Mutant type | Patient count | PPA (95% CI) |
NPA (95% CI) |
OPA (95% CI) |
|||
---|---|---|---|---|---|---|---|
TP | FN | TN | FP | ||||
L858R/L861Q | 15 | 0 | 14 | 1 |
100 79.61–100% |
93.33 70.18–98.81% |
96.67 83.33–99.41% |
S768I | 8 | 0 | 19 | 3 |
100 67.56–100% |
86.36 66.66–95.25% |
90 74.38–96.54% |
G719X | 1 | 0 | 29 | 0 |
100 20.65–100% |
100 88.30–100% |
100 88.65–100% |
19Del | 2 | 0 | 28 | 0 |
100 34.24–100% |
100 87.94–100% |
100 88.65–100% |
20ins | 5 | 1 | 19 | 5 |
83.33 43.65–96.99% |
79.17 59.53–90.76% |
80.00 62.69–90.50% |
T790M | 1 | 0 | 26 | 3 |
100 20.65–100% |
89.66 73.61–96.42% |
90 74.38–96.54% |
Overall | 17 | 1 | 3 | 9 |
94.44 74.24–99.01% |
25 8.89–53.23% |
66.67 48.78–80.77% |
TP true positive, FN false negative, TN true negative, FP false positive, PPA positive predict agreement, NPA negative predict agreement, OPA overall predict agreement, CI confidence interval.